Article
GATA2 Mutations Predict Poor Prognosis in Transplanted Myeloid Neoplasms.
Cancer medicine - 1 May 2026
Zhang Xian, Wang Bingjie, Dong Yujun, Wang Qingya, Wang Qian, Zhu Jialin, Wang Qingyun, Han Na, Li Yuan
Abstract excerpt
BACKGROUND: GATA binding protein 2 (GATA2) plays a crucial role in the differentiation, proliferation, and maintenance of hematopoietic stem cells (HSCs). GATA2 mutations have been identified in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), but the impact of somatic GATA2 mutations on prognosis remains controversial, especially on patients who undergo allogeneic hematopoietic stem cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
